Somanetics (SMTS) Reports Q1 In-Line; Re-affirms Guidance
More News related to SMTS
- Somanetics (SMTS) Signs with Raba Equity for Johns Hopkins Cerebral Autoregulation Tech
- Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University
- Somanetics Corporation To Present at UBS Global Life Sciences Conference and Maxim Group Growth Conference
- Somanetics (SMTS) Reports Mixed Q3 Results; Reaffirms Guidance
- Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009
More News related to Earnings
- Verizon (VZ) Executive McAdam Buys 17K Shares
- Herbalife (HLF) CEO Enters Trading Plan Covering 732K Shares
Somanetics (Nasdaq: SMTS) reports Q1 EPS of $0.10, cents better than the analyst estimate of $0.10. Revenues for the quarter were $11.2 million, versus the consensus of $10.91 million.
Somanetics reaffirms financial guidance for FY09.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.26Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
